040-000-496 Brivaracetam
| Type | Active Pharmaceutical ingredient |
| CAS No. | 357336-20-0 |
| Chemical Formula | C11H20N2O2 |
| Appearance | white powder |
| Packaging | customized |
| Assay | ≥99% |
| Related Products | Iopamidol, Iohexol, 2,6-Dichloropurine |
Description
Brivaracetam Introduction
Brivaracetam (trade name Briviact), a chemical analog of levetiracetam, is a racetam derivative with anticonvulsant (antiepileptic) properties.
Brivaracetam Specification
| CAS No. | 357336-20-0 |
| Chemical Formula | C11H20N2O2 |
| Appearance | white powder |
| Packaging | customized |
| Assay | ≥99% |
| Boiling Point | 409.3±28.0℃ |
| Density | 1.062 |
Brivaracetam Applications
Brivaracetam is a new generation of antiepileptic drugs, approved by the FDA for the treatment of localized seizures in patients with epilepsy 16 years of age and older, and can be used for laboratory research and pharmaceutical research development.
What is the mechanism of action of Brivaracetam?
Brivaracetam reduces excessive neuronal excitation and prevents epileptic seizures by binding reversibly to LTG receptors on neurons, thereby regulating the release of neurotransmitters at the presynaptic level.
What are the common side effects of Brivaracetam?
Common side effects include dizziness, fatigue, drowsiness, headache, nausea, and irritability. Some patients may experience mood swings or behavioral changes, such as anxiety and irritability.
What is the recommended dosage of Brivaracetam?
The initial dosage is typically 50 milligrams per day. Depending on the patient’s response and tolerance, the dose can be gradually increased to up to 200 milligrams per day. The specific dosage should follow the guidance of a healthcare professional.
How should Brivaracetam be stored?
Brivaracetam should be stored in a dry, cool place, away from direct sunlight and high temperatures. Keep the medication out of reach of children and store it according to the instructions on the medication packaging.
